This federal contract award is for the delivery of the pharmaceutical product INLYTA 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $11,421.17. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 25, 2025. The contract is not designated as a set-aside....
This federal contract award is for the delivery of Inlyta 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, for a ceiling value of $11,039.62. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of INLYTA 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $32,057.76 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 6, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of INLYTA 1 MG TABLET 180S to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $10,710.96 and a completion date of March 6, 2024. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,369.36 firm fixed-price delivery order contract covers the supply of Inlyta 5 mg tablets, a medication used to treat advanced renal cell carcinoma. The contract has an ultimate completion date of December 13, 2024 and was awarded on November 21, 2024. This award is associated with a larger $999,999,999...
This federal contract award is for the delivery of the pharmaceutical product "INLYTA 5 MG TABLET 60S" to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $66,237.72, is a delivery order contract with a firm fixed price pricing type, and has an ultimate completion date of August 2, 2024. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,075.39 firm fixed-price delivery order is for the supply of 4566187849 INLYTA 1 MG TABLET 180S, a prescription medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on October 23, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Inlyta 5 mg tablets to support military healthcare programs. The contract, valued at $32,057.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price. It has an ultimate completion date of November 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award, valued at $11,458.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INLYTA 1 MG TABLET 180S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a completion date of March 17, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,079.24, is for the delivery of 4566135586 - INLYTA 5 MG TABLET 60S. It is a firm fixed-price delivery order contract with a completion date of November 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...